You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Palmoplantar Pustulosis

Showing 1 - 25 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Palmoplantar Pustulosis Trial (Deucravacitinib)

Not yet recruiting
  • Palmoplantar Pustulosis
  • (no location specified)
Feb 1, 2023

Palmoplantar Pustulosis Trial in Obihiro, Sapporo (KHK4827, Placebo)

Active, not recruiting
  • Palmoplantar Pustulosis
  • Obihiro, Hokkaido, Japan
  • +1 more
Apr 4, 2022

Palmoplantar Pustulosis Trial in Germany (Apremilast)

Completed
Has Results
  • Palmoplantar Pustulosis
  • Bonn, Germany
  • +4 more
Sep 23, 2021

Palmoplantar Pustulosis Trial in Canada, Germany (RIST4721, Placebo)

Completed
Has Results
  • Palmoplantar Pustulosis
  • Calgary, Alberta, Canada
  • +16 more
Mar 8, 2022

Samples From Various Skin Conditions and Healthy Volunteers

Not yet recruiting
  • Acne
  • +5 more
  • Blood samples collection
  • +6 more
  • Montréal, Quebec, Canada
    Innovaderm Research Inc.
Aug 17, 2023

Palmoplantar Pustulosis Trial in Worldwide (RIST4721, Placebo)

Recruiting
  • Palmoplantar Pustulosis
  • Birmingham, Alabama
  • +35 more
Aug 8, 2022

Palmoplantar Pustulosis Trial in Japan (Apremilast, Placebo)

Recruiting
  • Palmoplantar Pustulosis
  • Nagakute-shi, Aichi, Japan
  • +37 more
Jul 22, 2022

Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)

Active, not recruiting
  • Palmoplantar Pustulosis (PPP)
  • Ichinomiya-shi, Aichi, Japan
  • +38 more
Mar 1, 2022

Palmoplantaris Pustulosis Trial in Japan (Apremilast, Placebo)

Completed
Has Results
  • Palmoplantaris Pustulosis
  • Ichinomiya, Aichi, Japan
  • +21 more
Dec 9, 2021

Palmoplantar Pustulosis Trial in Worldwide (Spesolimab)

Recruiting
  • Palmoplantar Pustulosis
  • Birmingham, Alabama
  • +65 more
Aug 9, 2022

Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A

Unknown status
  • Palmoplantar Pustulosis
  • Generalized Pustular Psoriasis
  • prevalence/incidence
  • (no location specified)
Sep 22, 2020

Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau, Pustular Psoriasis Trial run by the NIAMS (Anakinra)

Completed
Has Results
  • Sneddon-Wilkinson
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2021

Palmoplantar Pustulosis Trial in Japan (Guselkumab, Placebo)

Completed
Has Results
  • Palmoplantar Pustulosis
  • Asahikawa, Japan
  • +30 more
Jul 29, 2019

Psoriasis Trial in Worldwide (Spesolimab (low dose), Placebo, Spesolimab (high dose))

Completed
Has Results
  • Psoriasis
  • Spesolimab (low dose)
  • +2 more
  • Fredericton, New Brunswick, Canada
  • +17 more
Nov 7, 2019

Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo)

Completed
  • Psoriasis
  • Guselkumab 100 mg
  • Placebo
  • Bordeaux, France
  • +25 more
Dec 30, 2021

Palmoplantar Psoriasis, Plaque Psoriasis Trial in New York (Duobrii®)

Recruiting
  • Palmoplantar Psoriasis
  • Plaque Psoriasis
  • New York, New York
    Mount Sinai Downtown Union Square
Apr 19, 2021

Pustular Psoriasis (PP) Trial in Italy, Singapore, Switzerland (biological sampling, Phenotypic description, Photography)

Recruiting
  • Pustular Psoriasis (PP)
  • biological sampling
  • +2 more
  • Rome, Italy
  • +3 more
Jul 5, 2022

Palmoplantar Psoriasis, Genital Psoriasis Trial in Worldwide (Deucravacitinib, Placebo)

Not yet recruiting
  • Palmoplantar Psoriasis
  • Genital Psoriasis
  • Birmingham, Alabama
  • +24 more
Sep 12, 2023

Tildrakizumab in Difficult-to-treat Areas in Psoriasis

Recruiting
  • Psoriasis Palmaris
  • +4 more
  • Psoriasis clinical assessments
  • +3 more
  • Paris, France
    Service de Dermatologie- Hopital Saint Joseph
Jul 3, 2023

Palmoplantar Pustular Psoriasis Trial in Worldwide (Secukinumab 300mg, Secukinumab 150mg, Placebo)

Completed
Has Results
  • Palmoplantar Pustular Psoriasis
  • Secukinumab 300mg
  • +2 more
  • Feldkirch, Austria
  • +67 more
Jan 1, 2019

Psoriasis Trial in Irvine, Winston-Salem, Seattle (Etanercept, Placebo injections)

Completed
Has Results
  • Psoriasis
  • Etanercept
  • Placebo injections
  • Irvine, California
  • +2 more
Jun 10, 2021

Psoriasis Trial in Worldwide (Risankizumab, Placebo for Risankizumab)

Active, not recruiting
  • Psoriasis
  • Glendale, Arizona
  • +54 more
Mar 2, 2022

KPPP1, Pachyonychia, Congenital Trial in Tel Aviv (Serum chemistry, Hematology, Urinalysis)

Recruiting
  • KPPP1
  • Pachyonychia, Congenital
  • Serum chemistry
  • +7 more
  • Tel Aviv, Israel
    Sourasky Medical Center - Ichilov Hospital
Jun 23, 2022

Palmoplantar Psoriasis Trial (Brodalumab)

Unknown status
  • Palmoplantar Psoriasis
  • Brodalumab
  • (no location specified)
Nov 12, 2020

Ankylosing Spondylitis Trial in Germany (Secukinumab (AIN457) 150 mg s.c., Placebo - Secukinumab (AIN457) 150 mg s.c.)

Completed
Has Results
  • Ankylosing Spondylitis
  • Secukinumab (AIN457) 150 mg s.c.
  • Placebo - Secukinumab (AIN457) 150 mg s.c.
  • Bad Doberan, Germany
  • +38 more
Oct 7, 2021